What does finite lived intangible assets - gross mean?

This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.

Collegium Pharmaceutical, Inc. COLL Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

Avanos MedicalAVNS

$389.2M+5.8%

Pacira BioSciences, Inc.PCRX

$590.09M0.0%

JAN

Janus Living JAN

$27.59M-29.8%

ViatrisVTRS

——

Segments

By product

See full

Jornay PM$635M0.0%

Belbuca$360M0.0%

Symproic$70M0.0%

Symproic and other$70M0.0%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+17.9%

Enterprise value$869.67M-0.3%

P/E15.4×-6.9×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s finite lived intangible assets - gross?: Collegium Pharmaceutical, Inc. (COLL) reported finite lived intangible assets - gross of $1.59B in Q1 2026.
What does finite lived intangible assets - gross mean?: This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.